Literature DB >> 8162744

Control of breathing and respiratory muscle strength in patients with multiple sclerosis.

C Tantucci1, M Massucci, R Piperno, L Betti, V Grassi, C A Sorbini.   

Abstract

In 11 patients with moderately severe multiple sclerosis, lasting 11.2 +/- 7.3 years, in stable condition, and in 10 age- and sex-matched control subjects, we investigated lung function, respiratory muscle strength, and ventilatory control system. Respiratory muscle strength was assessed by measuring maximal inspiratory and expiratory mouth pressures (Pimax and Pemax, respectively). Respiratory central drive was evaluated in terms of neuromuscular (P0.1) and ventilatory (Ve) output, breathing room air and during CO2 rebreathing. In the absence of any significant impairment of lung function, patients showed a reduction of Pimax and Pemax amounting to about 40 percent and 60 percent of the predicted value at functional residual capacity (FRC), respectively; a significant, inverse correlation was found between both Pimax and Pemax at FRC and the severity score of the disease. While at rest Ve was similar to that of control subjects, baseline P0.1 was significantly higher in patients (1.97 +/- 0.79 vs 0.97 +/- 0.20 cm H2O, p < 0.005). Compared with the control group, during CO2 rebreathing P0.1/PetCO2 slope, although less steep, was not dissimilar in patients (0.34 +/- 0.13 vs 0.46 +/- 0.19 cm H2O/mm Hg, NS); on the other hand, Ve/PetCO2 slope was much lower in the patient group (1.93 +/- 0.91 vs 3.27 +/- 1.11 L/min/mm Hg, p < 0.01) and was significantly related to the functional stage of disease and to Pimax and Pemax values at FRC. These results indicate that in patients with clinically stable, moderately severe multiple sclerosis, the respiratory muscle function is abnormal. Moreover, the inspiratory drive at rest is increased and the drive response to CO2 appears normal, while the ventilatory response to CO2 is significantly impaired. Respiratory muscle weakness (and/or lack of coordination) could explain, at least in part, the lower ventilatory response in these patients, whereas the mechanism of increased rate of the initial inspiratory force generation remains unclear.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162744     DOI: 10.1378/chest.105.4.1163

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Effects of a 10-week inspiratory muscle training program on lower-extremity mobility in people with multiple sclerosis: a randomized controlled trial.

Authors:  Lucinda Pfalzer; Donna Fry
Journal:  Int J MS Care       Date:  2011

2.  Maximal expiratory pressure in residential and non-residential school children.

Authors:  Dipayan Choudhuri; Manjunath Aithal; Vasant A Kulkarni
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

Review 3.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 4.  [Therapy of day time fatigue in patients with multiple sclerosis].

Authors:  Udo A Zifko
Journal:  Wien Med Wochenschr       Date:  2003

5.  Abdominal Binding Improves Neuromuscular Efficiency of the Human Diaphragm during Exercise.

Authors:  Sara J Abdallah; David S Chan; Robin Glicksman; Cassandra T Mendonca; Yuanming Luo; Jean Bourbeau; Benjamin M Smith; Dennis Jensen
Journal:  Front Physiol       Date:  2017-05-31       Impact factor: 4.566

6.  GI distress: A breath of fresh air in respiratory homeostasis.

Authors:  Richard Kinkead; Jean-Philippe Rousseau; Tara A Janes
Journal:  EBioMedicine       Date:  2019-04-04       Impact factor: 8.143

7.  Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple Sclerosis.

Authors:  Elisabeth Westerdahl; Martin Gunnarsson; Anna Wittrin; Ylva Nilsagård
Journal:  Mult Scler Int       Date:  2021-06-14

8.  Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients.

Authors:  Diego Gatta; Marco Fredi; Giovanni Aliprandi; Laura Pini; Claudio Tantucci
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.